The Association between Erection Hardness Grading Scale and International Index of Erectile Function in Men with Erectile Dysfunction Treated with Sildenafil Citrate

Aslan Y., Tuncel A., Aydin O., Balci M., KARABULUT E., Atan A.

UROLOGIA INTERNATIONALIS, cilt.86, sa.4, ss.434-438, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 86 Sayı: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1159/000324100
  • Dergi Adı: UROLOGIA INTERNATIONALIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.434-438
  • Gazi Üniversitesi Adresli: Hayır

Özet

Introduction: To evaluate the association between the first 5-item version of the International Index of Erectile Function (IIEF-5) and Erection Hardness Grading Scale (EHGS) scores in patients who received sildenafil citrate treatment due to erectile dysfunction (ED). Patients and Methods: A total of 81 men with ED lasting for 6 months or longer were included in this study. Mean age was 51 years (range 21-75). All patients were given 50 mg sildenafil citrate (Viagra (R)) 4 times a week during an 8-week period and they were asked to attempt sexual intercourse when they used the drug. Results: The mean pretreatment IIEF-5 and EHGS scores were 6.7 +/- 2.5 and 1.7 +/- 0.5, respectively. These values were 15.3 +/- 5.1 and 2.8 +/- 0.6 after the treatment, respectively. There were statistically significant differences in all scores between before and after treatment for IIEF-5 and EHGS scores (p < 0.001). We found a very strong association between IIEF-5 and EHGS scores in the pretreatment period (gamma = 0.916, p < 0.001). However, there was a fair agreement between IIEF-5 and EHGS scores (kappa coefficient: 0.375). Conclusions: Our experience showed that there was no significant agreement between the IIEF-5 and EHGS scores in patients treated with sildenafil citrate. Copyright (C) 2011 S. Karger AG, Basel